CV6 THERAPEUTICS
CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.
CV6 THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Belfast, Belfast, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cv6t.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0) 28 9097 2674
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome Apache
Similar Organizations
AlcaSynn Pharmaceuticals GmbH
Drug development company focusing on small molecules of the morphinan group. In 2006 AlcaSynn was acquired by Sanochemia Pharmazeutika
Beta Pharma
Beta Pharma is an emerging pharmaceutical company dedicated to the discovery,and commercialization of innovative late stage therapies
BioZeus
BioZeus is a drug development firm that converts early-stage drug candidates into new therapies.
DuoCort Pharma
DuoCort Pharma is a drug development company focused on improving glucocorticoid therapy. The company has its origins among researchers at
G7 Therapeutics
G7 Therapeutics is focused on stabilizing GPCRs for the discovery of novel medicines.
Laboratorios Gebro Pharma
Laboratorios Gebro Pharma is focuses on the development and commercialization of treatments against pain and inflammation.
MetP Pharma
MetP Pharma is a privately held company, focusing on the nasal delivery of drugs to the systemic circulation and brain.
Onco-NX
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents.
QUANTRO Therapeutics
QUANTRO Therapeutics is a privately funded research company dedicated to the discovery and development of novel effective therapeutics.
Official Site Inspections
http://www.cv6t.com
- Host name: 167.99.88.200
- IP address: 167.99.88.200
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "CV6 Therapeutics"
CV6 Therapeutics - an early stage drug development …
News CV6 Announces Initiation of Patient Dosing in CV6-168 Phase 1a Clinical Trial. CV6 Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6 …See details»
Our Company - CV6 Therapeutics
Over the last 25 years, our research has focused on identifying molecular vulnerabilities in cancer cells and abnormal immune cells that can be targeted with novel and innovative therapeutics. …See details»
CV6 Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +44 (0) 28 9097 2674 CV6 Therapeutics is a drug development company focused on the discovery, …See details»
CV6-1271 - Drug Targets, Indications, Patents - Synapse
Originator Organization. CV6 Therapeutics (NI) Ltd. Active Organization-Inactive Organization. CV6 Therapeutics (NI) Ltd. Drug Highest Phase Pending Preclinical. First Approval Date- ...See details»
CV6 Therapeutics - VentureRadar
Develops innovative therapies targeting Uracil-DNA biology to treat cancer and inflammatory diseases, advancing compound CV6-168 through Phase 1a clinical trials.See details»
Overview - CV6 Therapeutics
Uncontrolled growth and abnormal cellular behaviour are traits of cancer cells and immune cells that contribute to autoimmune and inflammatory disorders. CV6 Therapeutics is developing …See details»
CV6 Therapeutics - Products, Competitors, Financials, Employees ...
Cv6t.com. Overview & Products; Financials; Founded Year 2012. Stage Grant | Alive. Total Raised $12.55M. Last Raised $3.35M | 2 yrs ago. About CV6 Therapeutics. CV6 Therapeutics …See details»
CV6 Therapeutics - PitchBook
CV6 Therapeutics General Information Description. Developer of a drug development company intended for the treatment of human diseases and also to treat cancer. The company analyzes …See details»
CV6 Therapeutics Announces Initiation of Patient Dosing in
Aug 15, 2024 For additional information, please visit CV6’s website at www.cv6t.com and follow us on Linkedin. Media Contacts. CV6 Therapeutics . Dr Robert Ladner, CEO +44 (0) 7500 …See details»
CV6 Therapeutics - Company Profile - Tracxn
Aug 30, 2024 CV6 Therapeutics - Developer of combination therapies for the treatment of cancer. Raised a total funding of $5.63M over 2 rounds from 6 investors. Founded by Robert …See details»
CV6 Therapeutics - Craft
CV6 Therapeutics is a pharmaceutical company. It develops CV6-168, a small molecule drug for cancer treatment. The company is focused on investigating the mechanism by which cancer …See details»
CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug
CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug ... - BioSpaceSee details»
Recent Posts - CV6 Therapeutics
May 13, 2024 Founded in 1964, the American Society of Clinical Oncology is the world’s leading professional organization for physicians and oncology professionals caring for and improving …See details»
CV6 Therapeutics - Overview, News & Similar companies - ZoomInfo
CV6 Therapeutics contact info: Phone number: +44 2890972674 Website: www.cv6t.com What does CV6 Therapeutics do? CV6 Therapeutics is committed to improving patient care through …See details»
CV6 Therapeutics Company Information - Funding, Investors, and …
Https://cv6t.com. Drug development company focused on discovering, developing, and commercializing novel therapies. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR …See details»
News - CV6 Therapeutics
Dec 14, 2023 CV6 Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168 Belfast, UK, 15 August …See details»
CV6 Therapeutics Receives MHRA Approval for Novel Cancer …
Dec 14, 2023 CV6 CEO and Founder Dr Robert Ladner said, “This regulatory approval is a key milestone as we progress CV6-168 into a first-in-human Phase 1a clinical trial.Our innovative …See details»
Oncology - CV6 Therapeutics
Early stage drug development company. Oncology. CV6 Therapeutics is dedicated to the development of novel and innovative therapeutics to improve and extend the lives of patients …See details»
CV6 Therapeutics Receives MHRA Approval for Novel Cancer
Dec 14, 2023 [email protected]. Scius Communications. Katja Stout +447789435990 [email protected]. Daniel Gooch +447747875479 …See details»
Pipeline - CV6 Therapeutics
Uncontrolled growth and abnormal cellular behaviour are traits of both cancer cells and autoimmune and inflammatory disorders. By creating medicines to block the growth and …See details»